↓ Skip to main content

Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review

Overview of attention for article published in Frontiers in endocrinology, December 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review
Published in
Frontiers in endocrinology, December 2023
DOI 10.3389/fendo.2023.1301093
Pubmed ID
Authors

Xueqin Xie, Changchun Wu, Yuduo Hao, Tianyu Wang, Yuhe Yang, Peiling Cai, Yang Zhang, Jian Huang, Kejun Deng, Dan Yan, Hao Lin

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 12%
Student > Bachelor 3 12%
Researcher 1 4%
Student > Doctoral Student 1 4%
Student > Master 1 4%
Other 0 0%
Unknown 16 64%
Readers by discipline Count As %
Unspecified 3 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Biochemistry, Genetics and Molecular Biology 1 4%
Nursing and Health Professions 1 4%
Psychology 1 4%
Other 1 4%
Unknown 16 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2023.
All research outputs
#20,767,513
of 26,370,291 outputs
Outputs from Frontiers in endocrinology
#6,109
of 13,442 outputs
Outputs of similar age
#256,444
of 382,886 outputs
Outputs of similar age from Frontiers in endocrinology
#226
of 679 outputs
Altmetric has tracked 26,370,291 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,442 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 382,886 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 679 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.